Xylocaine 2% Inj, 20ml
Overview
What is this medicine?
How to Use This Medicine
If you need to store this medication at home, consult with your doctor, nurse, or pharmacist to determine the proper storage procedure.
If you miss a dose, contact your doctor promptly to receive guidance on the appropriate course of action.
Lifestyle & Tips
- Report any unusual sensations (e.g., dizziness, ringing in ears, numbness around mouth) during or after administration.
- Avoid activities requiring full sensation or coordination until the anesthetic effect has worn off (e.g., driving, operating machinery, eating if mouth is numb).
Available Forms & Alternatives
Available Strengths:
- Xylocaine 4% Top Soln
- Xylocaine-Mpf 2% Inj, 10ml
- Xylocaine 2% Inj, 10ml
- Xylocaine-Mpf 1% Inj, 5ml
- Xylocaine 2% Inj, 20ml
- Xylocaine-Mpf 1% Inj, 30ml
- Xylocaine 2% Inj, 50ml
- Xylocaine-Mpf 0.5% Inj, 50ml
- Xylocaine-Mpf 1% Inj, 2ml
- Xylocaine-Mpf 2% Inj, 5ml
- Xylocaine 1% Inj, 20ml
- Xylocaine-Mpf 2% Inj, 2ml
- Xylocaine-Mpf 1% Inj, 10ml
- Xylocaine 1% Inj, 50ml
- Xylocaine 0.5% Inj, 50ml
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following signs or symptoms, contact your doctor or seek medical attention immediately:
Allergic Reaction: Rash, hives, itching, red, swollen, blistered, or peeling skin with or without fever, wheezing, tightness in the chest or throat, trouble breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat.
Methemoglobinemia: Blue or gray discoloration of the lips, nails, or skin, abnormal heartbeat, seizures, severe dizziness or fainting, severe headache, excessive sleepiness, feeling tired or weak, or shortness of breath. This rare condition can be life-threatening if left untreated.
Acidosis (Too Much Acid in the Blood): Confusion, rapid breathing, rapid heartbeat, abnormal heartbeat, severe stomach pain, nausea, vomiting, excessive sleepiness, shortness of breath, or feeling extremely tired or weak.
Respiratory Problems: Trouble breathing, slow breathing, or shallow breathing.
Neurological Symptoms: Feeling lightheaded, sleepy, confused, or experiencing blurred vision.
Cardiovascular Issues: Slow heartbeat.
Nervous System Symptoms: Feeling nervous and excitable, trouble speaking, burning, numbness, or tingling sensations, restlessness, anxiety, changes in vision, ringing in the ears, dizziness or fainting, severe headache, twitching, shakiness, seizures, feeling hot or cold, metallic taste, or chest pain.
Mood Changes: Changes in mood or emotional state.
Additional Side Effects of Spinal Injection:
Sexual Dysfunction: Difficulty getting or maintaining an erection.
Motor Function: Loss of movement or control over stools and urine.
* Urinary Problems: Trouble passing urine.
Other Side Effects:
Not all side effects are severe, and many people may experience no side effects or only minor ones. However, if you notice any side effects that bother you or persist, contact your doctor for guidance. This is not an exhaustive list of possible side effects. If you have questions or concerns, consult your doctor.
Reporting Side Effects:
You can report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch. Your doctor can also provide medical advice and guidance on managing side effects.
Seek Immediate Medical Attention If You Experience:
- Dizziness or lightheadedness
- Ringing in the ears (tinnitus)
- Numbness or tingling around the mouth
- Blurred or double vision
- Tremors or muscle twitching
- Feeling anxious or restless
- Difficulty breathing
- Unusual drowsiness or confusion
- Slow or irregular heartbeat
Before Using This Medicine
To ensure safe treatment, inform your doctor of the following:
Any allergies you have to this medication, its components, or other substances, including foods and drugs. Describe the allergic reactions you experienced.
If you are scheduled to receive this medication via spinal injection, notify your doctor if you have:
+ Heart block
+ Severe bleeding
+ Severe infection
+ An infection at the injection site
This list is not exhaustive. It is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health conditions with your doctor and pharmacist. They will help determine if it is safe to take this medication with your other treatments and health issues. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
Precautions & Cautions
It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.
Risk of Methemoglobinemia
A severe blood disorder called methemoglobinemia has been associated with drugs like this one. Your risk may be increased if you have:
- Glucose-6-phosphate dehydrogenase (G6PD) deficiency
- Heart problems
- Lung problems
- Are taking certain other medications
- Are an infant younger than 6 months of age
If you have a history of methemoglobinemia, notify your doctor.
Sulfite Allergy
If you are allergic to sulfites, consult with your doctor, as some products may contain sulfites.
Caution with Daily Activities
Avoid driving and engaging in activities that require alertness until the effects of this medication have worn off and you feel fully awake.
Post-Treatment Precautions
If you are discharged before the numbness has resolved, protect the treated area from injury until you have regained sensation.
Special Considerations
- If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.
- If the patient is a child, use this medication with caution, as the risk of certain side effects may be higher in children.
Pregnancy and Breastfeeding
Inform your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. You will need to discuss the potential benefits and risks to you and your baby.
Spinal Injection
If this medication is administered into the spine, it may cause temporary loss of feeling and motor function in the lower half of your body. Do not attempt to get out of bed or perform other activities until feeling and motor function have returned to normal.
Mouth and Dental Procedures
Do not eat while your mouth is numb, as you may accidentally bite your tongue.
Overdose Information
Overdose Symptoms:
- Severe dizziness or lightheadedness
- Seizures
- Unconsciousness
- Respiratory arrest (stopping breathing)
- Cardiac arrest (heart stopping)
What to Do:
Seek immediate medical attention. Call 911 or your local emergency number. In the US, you can call Poison Control at 1-800-222-1222.
Drug Interactions
Major Interactions
- Antiarrhythmics (e.g., amiodarone, mexiletine, procainamide, quinidine): Increased risk of cardiac depression and arrhythmias.
- Beta-blockers (e.g., propranolol, metoprolol): Decreased hepatic metabolism of lidocaine, leading to increased lidocaine levels and toxicity.
- Cimetidine: Decreased hepatic metabolism of lidocaine, leading to increased lidocaine levels and toxicity.
- Other local anesthetics: Additive systemic toxicity.
Moderate Interactions
- CYP1A2 inhibitors (e.g., fluvoxamine, ciprofloxacin): May increase lidocaine levels.
- CYP3A4 inhibitors (e.g., macrolide antibiotics, azole antifungals, protease inhibitors): May increase lidocaine levels.
- Skeletal muscle relaxants (e.g., succinylcholine): Prolonged neuromuscular blockade.
- Phenytoin: May increase lidocaine metabolism (decreased lidocaine levels) or increase risk of cardiac depression.
Minor Interactions
- Cholinergic drugs: May antagonize effects.
Monitoring
Baseline Monitoring
Rationale: To identify contraindications, risk factors for toxicity, and potential drug interactions.
Timing: Prior to administration
Rationale: To establish baseline and detect early signs of systemic toxicity.
Timing: Prior to administration
Routine Monitoring
Frequency: Every 5-15 minutes during and immediately after administration, then as clinically indicated.
Target: Within patient's normal limits; stable.
Action Threshold: Significant changes (e.g., bradycardia, hypotension, respiratory depression) warrant immediate intervention.
Frequency: Continuously during and immediately after administration.
Target: Alert and oriented, no signs of CNS excitation or depression.
Action Threshold: Dizziness, tinnitus, perioral numbness, tremors, seizures, somnolence.
Frequency: Continuous during and after administration.
Target: Normal sinus rhythm, no conduction abnormalities.
Action Threshold: Bradycardia, heart block, QRS widening, ventricular arrhythmias.
Symptom Monitoring
- Lightheadedness
- Dizziness
- Tinnitus
- Perioral numbness
- Metallic taste
- Blurred vision
- Tremors
- Muscle twitching
- Seizures
- Drowsiness
- Confusion
- Respiratory depression
- Bradycardia
- Hypotension
- Cardiac arrest
Special Patient Groups
Pregnancy
Lidocaine is generally considered safe for use during pregnancy when clinically indicated and administered at appropriate doses. It crosses the placenta. Category B.
Trimester-Specific Risks:
Lactation
Lidocaine is excreted into breast milk in small amounts. The amount ingested by the infant is typically very low and unlikely to cause adverse effects. Considered compatible with breastfeeding (L2).
Pediatric Use
Use with caution, especially in neonates and infants, due to immature hepatic metabolism and higher susceptibility to systemic toxicity. Dosing must be carefully calculated based on weight and age. Avoid formulations with preservatives (e.g., benzyl alcohol) in neonates.
Geriatric Use
Use with caution. Elderly patients may be more susceptible to systemic toxicity due to decreased hepatic function, reduced protein binding, and altered body composition. Consider lower doses and monitor closely.
Clinical Information
Clinical Pearls
- Always aspirate prior to injection to avoid intravascular administration, which can lead to rapid systemic toxicity.
- The addition of epinephrine prolongs the duration of action and reduces systemic absorption, but should be avoided in areas with end-arterial circulation (e.g., fingers, toes, nose, penis, ears) due to risk of ischemia.
- Monitor for signs of CNS toxicity (e.g., perioral numbness, tinnitus, dizziness, tremors) as these often precede more severe cardiovascular toxicity.
- Lipid emulsion therapy (Intralipid) is the antidote for severe local anesthetic systemic toxicity (LAST).
- The 2% concentration (20 mg/mL) is potent; ensure correct dilution and volume for the intended procedure and patient weight.
Alternative Therapies
- Bupivacaine (longer acting local anesthetic)
- Ropivacaine (longer acting local anesthetic, less cardiotoxic than bupivacaine)
- Mepivacaine (intermediate acting local anesthetic)
- Prilocaine (intermediate acting local anesthetic)
- Chloroprocaine (short acting local anesthetic)